BMRN
Price
$55.17
Change
+$1.07 (+1.98%)
Updated
Jun 27 closing price
Capitalization
10.58B
37 days until earnings call
TECH
Price
$51.84
Change
-$0.96 (-1.82%)
Updated
Jun 27 closing price
Capitalization
8.13B
44 days until earnings call
Interact to see
Advertisement

BMRN vs TECH

Header iconBMRN vs TECH Comparison
Open Charts BMRN vs TECHBanner chart's image
BioMarin Pharmaceutical
Price$55.17
Change+$1.07 (+1.98%)
Volume$3.33M
Capitalization10.58B
Bio-Techne
Price$51.84
Change-$0.96 (-1.82%)
Volume$2.49M
Capitalization8.13B
BMRN vs TECH Comparison Chart in %
Loading...
BMRN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TECH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BMRN vs. TECH commentary
Jun 29, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BMRN is a Buy and TECH is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 29, 2025
Stock price -- (BMRN: $55.17 vs. TECH: $51.84)
Brand notoriety: BMRN and TECH are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BMRN: 165% vs. TECH: 104%
Market capitalization -- BMRN: $10.58B vs. TECH: $8.13B
BMRN [@Biotechnology] is valued at $10.58B. TECH’s [@Biotechnology] market capitalization is $8.13B. The market cap for tickers in the [@Biotechnology] industry ranges from $299.85B to $0. The average market capitalization across the [@Biotechnology] industry is $2.3B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BMRN’s FA Score shows that 0 FA rating(s) are green whileTECH’s FA Score has 1 green FA rating(s).

  • BMRN’s FA Score: 0 green, 5 red.
  • TECH’s FA Score: 1 green, 4 red.
According to our system of comparison, TECH is a better buy in the long-term than BMRN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BMRN’s TA Score shows that 5 TA indicator(s) are bullish while TECH’s TA Score has 6 bullish TA indicator(s).

  • BMRN’s TA Score: 5 bullish, 2 bearish.
  • TECH’s TA Score: 6 bullish, 3 bearish.
According to our system of comparison, both BMRN and TECH are a good buy in the short-term.

Price Growth

BMRN (@Biotechnology) experienced а +0.31% price change this week, while TECH (@Biotechnology) price change was +3.91% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.13%. For the same industry, the average monthly price growth was +31.22%, and the average quarterly price growth was +12.91%.

Reported Earning Dates

BMRN is expected to report earnings on Aug 05, 2025.

TECH is expected to report earnings on Aug 12, 2025.

Industries' Descriptions

@Biotechnology (+4.13% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BMRN($10.6B) has a higher market cap than TECH($8.13B). TECH has higher P/E ratio than BMRN: TECH (62.46) vs BMRN (20.43). BMRN YTD gains are higher at: -16.066 vs. TECH (-27.826). BMRN has higher annual earnings (EBITDA): 777M vs. TECH (283M). BMRN has more cash in the bank: 1.27B vs. TECH (141M). TECH has less debt than BMRN: TECH (423M) vs BMRN (602M). BMRN has higher revenues than TECH: BMRN (2.95B) vs TECH (1.21B).
BMRNTECHBMRN / TECH
Capitalization10.6B8.13B130%
EBITDA777M283M275%
Gain YTD-16.066-27.82658%
P/E Ratio20.4362.4633%
Revenue2.95B1.21B244%
Total Cash1.27B141M902%
Total Debt602M423M142%
FUNDAMENTALS RATINGS
BMRN vs TECH: Fundamental Ratings
BMRN
TECH
OUTLOOK RATING
1..100
6289
VALUATION
overvalued / fair valued / undervalued
1..100
62
Fair valued
4
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
7080
PRICE GROWTH RATING
1..100
8462
P/E GROWTH RATING
1..100
9943
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECH's Valuation (4) in the Biotechnology industry is somewhat better than the same rating for BMRN (62). This means that TECH’s stock grew somewhat faster than BMRN’s over the last 12 months.

TECH's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as BMRN (100). This means that TECH’s stock grew similarly to BMRN’s over the last 12 months.

BMRN's SMR Rating (70) in the Biotechnology industry is in the same range as TECH (80). This means that BMRN’s stock grew similarly to TECH’s over the last 12 months.

TECH's Price Growth Rating (62) in the Biotechnology industry is in the same range as BMRN (84). This means that TECH’s stock grew similarly to BMRN’s over the last 12 months.

TECH's P/E Growth Rating (43) in the Biotechnology industry is somewhat better than the same rating for BMRN (99). This means that TECH’s stock grew somewhat faster than BMRN’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BMRNTECH
RSI
ODDS (%)
Bullish Trend 3 days ago
72%
N/A
Stochastic
ODDS (%)
Bullish Trend 3 days ago
63%
Bearish Trend 3 days ago
70%
Momentum
ODDS (%)
N/A
Bullish Trend 3 days ago
70%
MACD
ODDS (%)
Bullish Trend 3 days ago
68%
Bullish Trend 3 days ago
70%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
55%
Bullish Trend 3 days ago
68%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
63%
Bullish Trend 3 days ago
66%
Advances
ODDS (%)
Bullish Trend 20 days ago
59%
Bullish Trend 4 days ago
70%
Declines
ODDS (%)
Bearish Trend 4 days ago
64%
Bearish Trend 17 days ago
72%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
73%
Bearish Trend 3 days ago
70%
Aroon
ODDS (%)
Bearish Trend 3 days ago
63%
Bullish Trend 3 days ago
60%
View a ticker or compare two or three
Interact to see
Advertisement
BMRN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TECH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
ARKQ88.340.55
+0.63%
ARK Autonomous Technology&Robotics ETF
IPKW48.460.07
+0.15%
Invesco Intl BuyBack Achiev™ ETF
JCTR80.93N/A
N/A
JPMorgan Carbon Transition US Eq ETF
MAGG20.32-0.03
-0.12%
Madison Aggregate Bond ETF
CCSB20.40-0.04
-0.20%
Carbon Collective Short Dur Grn Bd ETF

BMRN and

Correlation & Price change

A.I.dvisor indicates that over the last year, BMRN has been loosely correlated with ITOS. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if BMRN jumps, then ITOS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BMRN
1D Price
Change %
BMRN100%
+1.98%
ITOS - BMRN
49%
Loosely correlated
-0.70%
IBO - BMRN
46%
Loosely correlated
-18.26%
IONS - BMRN
42%
Loosely correlated
N/A
TECH - BMRN
40%
Loosely correlated
-1.82%
KRYS - BMRN
40%
Loosely correlated
-2.60%
More

TECH and

Correlation & Price change

A.I.dvisor indicates that over the last year, TECH has been loosely correlated with ADPT. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if TECH jumps, then ADPT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TECH
1D Price
Change %
TECH100%
-1.82%
ADPT - TECH
49%
Loosely correlated
-3.04%
SYRE - TECH
49%
Loosely correlated
-4.99%
TRDA - TECH
48%
Loosely correlated
-1.57%
DNLI - TECH
47%
Loosely correlated
-2.69%
XNCR - TECH
47%
Loosely correlated
-3.10%
More